Thought Leadership
Thought Leadership, Rare diseases
Launching successful patient support programs for rare disease patients across Europe
Thought Leadership, Rare diseases
Market access for orphan drugs in Switzerland: a guide for Biotechs
Thought Leadership, Cancer
The benefits of digitally collecting PROMs to study patient wellbeing.
Thought Leadership, Rare diseases
The impact of real-world data in gaining access to the European orphan drugs market.
Thought Leadership, Long-term conditions
White Paper: Quality of Life
Thought Leadership, Cancer
White Paper: Investigating Patient Benefits in Home vs. Clinic-Based Treatment
Thought Leadership
The role of real-world evidence in reducing clinical uncertainty in cancer treatment.
Thought Leadership, Rare diseases
Navigating expanded access in Europe: a strategic blueprint for biotech leaders
Thought Leadership, Rare diseases
Strategies for entering the European orphan drugs market